Video | 08 February 2019 TB survivors challenge J&J's patent on TB drug in India TUBERCULOSIS India Phumeza and Nandita suffered permanent hearing loss because of toxic drugs used to treat their drug-resistant TB. Now they’re working to ensure that this doesn’t happen to anyone else. Read, watch, share Filter by - Any -ExplainerFeature storyIssue briefLetterNewsletterPhoto storyPress releaseReportResearch articleSpeechStatementVideo Photograph by Alexis Huguet Feature story Feature story | 23 February 2017 Tuberculosis Eswatini New hope for patients with drug-resistant tuberculosis 6 min Photograph by Atul Loke/Panos Pictures Press release Press release | 30 January 2017 Tuberculosis India Health groups call on Government of India to urgently make lifesaving TB drug available 6 min Letter Letter | 15 December 2016 Tuberculosis Letter to Johnson & Johnson on ensuring widespread access to bedaquiline for the treatment of tuberculosis Photograph by MSF Feature story Feature story | 07 November 2016 Tuberculosis Tajikistan TB Patients in Tajikistan Celebrate New Treatment Access Photograph by Sydelle Willow Smith Press release Press release | 26 October 2016 Tuberculosis MSF reports on use of the new TB drugs bedaquiline and delamanid Video Video | 25 October 2016 Tuberculosis XDR-TB patient successfully completes treatment Research article | 07 April 2016 Tuberculosis Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis Press release Press release | 21 March 2016 Tuberculosis Just 2% of people with the severest cases of drug-resistant TB currently have access to new, more effective treatments 4 min Load More
Photograph by Alexis Huguet Feature story Feature story | 23 February 2017 Tuberculosis Eswatini New hope for patients with drug-resistant tuberculosis 6 min
Photograph by Atul Loke/Panos Pictures Press release Press release | 30 January 2017 Tuberculosis India Health groups call on Government of India to urgently make lifesaving TB drug available 6 min
Letter Letter | 15 December 2016 Tuberculosis Letter to Johnson & Johnson on ensuring widespread access to bedaquiline for the treatment of tuberculosis
Photograph by MSF Feature story Feature story | 07 November 2016 Tuberculosis Tajikistan TB Patients in Tajikistan Celebrate New Treatment Access
Photograph by Sydelle Willow Smith Press release Press release | 26 October 2016 Tuberculosis MSF reports on use of the new TB drugs bedaquiline and delamanid
Research article | 07 April 2016 Tuberculosis Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis
Press release Press release | 21 March 2016 Tuberculosis Just 2% of people with the severest cases of drug-resistant TB currently have access to new, more effective treatments 4 min
